tert-butyl 2,2,3,3,5,5,6,6-octadeuteriopiperazine-1-carboxylate, 97, 1g

4-Benzyl 1-(tert-butyl) 2-methyl (S)-piperazine-1,2,4-tricarboxylate, 98+%, 250mg

3,5-Dichloro-2-fluoropyridine>98.0%(GC)5g

tert-butyl (2S)-2-[4-(4-ethynylphenyl)-1H-imidazol-2-yl]pyrrolidine-1-carboxylate, 100mg

4-Hydroxy-3-(trifluoromethyl)benzoic acid, 98.0%, 1g

HPLC-Anschlusskappen GL45, 2 Anschlüsse, f. Schläuche Ø innen x außen 0,8 x 1,6mm, Durchgangsbohrung 0,8 mm, 1 Stück

9-Amino-1,2,3,4-tetrahydroacridine hydrochloride hydrate, 97.0%, 1g

bicyclo[3.2.2]nonan-1-amine hydrochloride, 95.0%, 100mg

Butyl 2-((3-(trifluoromethyl)phenyl)amino)benzoate, 95.0%, 100g

6,7-Dimethoxy-1-{[3-(trifluoromethyl)phenoxy]methyl}- 1,2,3,4-tetrahydroisoquinoline, 95.0%, 500mg

Tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-6-(1-propoxyvinyl)-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate, 98%, 100mg

4-Bromo-3-chlorotoluene, 99.0%, 5g

2-Fluoro-4-iodopyridine, 98.0%, 5g